Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

274
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
274
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

554
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
554
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Neural Regulation01:37

Neural Regulation

39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fructose impairs brown adipogenesis by promoting thyroid hormone resistance in differentiated brown adipocytes.

Biology open·2026
Same author

The Epidemiological and Toxicological Intersection of Air Pollution and Dementia.

Reviews of environmental contamination and toxicology·2026
Same author

FMW-YOLO: A Frequency-Enhanced and Multi-Scale Context-Aware Framework for PCB Defect Detection.

Micromachines·2026
Same author

Microglial Lag3 Drives α-Synuclein-induced Neurotoxic Activated (A1) Astrocytes and Neurodegeneration.

bioRxiv : the preprint server for biology·2026
Same author

Highly sensitive chemiluminescence imaging of misfolded proteins in neurodegenerative models.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Genome Mining Guided Discovery of Macrocyclic Sesterterpenoids with Anti-MRSA and Anti-Neuroinflammatory Activities.

Journal of agricultural and food chemistry·2025

Related Experiment Video

Updated: Jul 7, 2025

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies
12:13

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

7.2K

Cell Therapy for Parkinson's Disease.

Surabhi Shastry1,2, Junkai Hu1,2, Mingyao Ying2,3

  • 1Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Pharmaceutics
|December 23, 2023
PubMed
Summary
This summary is machine-generated.

Induced pluripotent stem cells (iPSCs) offer a novel cell therapy for Parkinson's Disease (PD) by regenerating lost dopaminergic neurons. This approach addresses neurodegeneration, unlike current symptomatic treatments for PD.

Keywords:
Parkinson’s diseaseallogeneic transplantationautologous transplantationdopaminergic neuroninduced pluripotent stem cellssubstantia nigra

More Related Videos

Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

8.0K
Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

167

Related Experiment Videos

Last Updated: Jul 7, 2025

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies
12:13

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

7.2K
Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

8.0K
Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

167

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Parkinson's Disease (PD) involves progressive loss of dopaminergic neurons, causing motor symptoms like tremor and rigidity.
  • Current PD therapies offer symptomatic relief but do not halt underlying neurodegeneration.
  • Cellular reprogramming and induced pluripotent stem cells (iPSCs) present new therapeutic avenues.

Purpose of the Study:

  • To review the role of dopamine in PD.
  • To highlight the regenerative potential of iPSCs for treating PD.
  • To compare iPSC-based therapies with existing PD treatments.

Main Methods:

  • This is a narrative review.
  • It synthesizes information on dopamine's effects in PD.
  • It examines iPSC differentiation and therapeutic applications.

Main Results:

  • iPSCs can be differentiated into dopaminergic neurons, crucial for PD treatment.
  • iPSC therapy holds promise for addressing PD's neurodegenerative basis.
  • The review explores strategies to enhance transplanted neuron survival.

Conclusions:

  • iPSCs offer a promising regenerative approach for Parkinson's Disease.
  • This technology has the potential to overcome limitations of current symptomatic treatments.
  • Further research into reinforcing iPSC therapy is essential for long-term efficacy.